Author:
Curnis Flavio,Sacchi Angelina,Borgna Laura,Magni Fulvio,Gasparri Anna,Corti Angelo
Publisher
Springer Science and Business Media LLC
Subject
Biomedical Engineering,Molecular Medicine,Applied Microbiology and Biotechnology,Bioengineering,Biotechnology
Reference35 articles.
1. Fiers, W. Biologic therapy with TNF: preclinical studies In Biologic therapy of cancer: principles and practice. (eds DeVita, V., Hellman, S. & Rosenberg, S.) 295–327 (J.B. Lippincott, Philadelphia; 1995).
2. Carswell, E.A. et al. An endotoxin-induced serum factor that causes necrosis of tumors . Proc. Natl. Acad. Sci. USA 72, 3666– 3670 (1975).
3. Fraker, D.L., Alexander, H.R. & Pass, H.I. Biologic therapy with TNF: systemic administration and isolation perfusion. In Biologic therapy of cancer: principles and practice. (eds DeVita V., Hellman, S. & Rosenberg, S.) 329–345 (J.B. Lippincott, Philadelphia; 1995).
4. Lienard, D., Ewalenko, P., Delmotte, J.J., Renard, N. & Lejeune, F.J. High-dose recombinant tumor necrosis factor alpha in combination with interferon gamma and melphalan in isolation perfusion of the limbs for melanoma and sarcoma. J. Clin. Oncol. 10, 52–60 (1992).
5. Eggermont, A.M. et al. Isolated limb perfusion with high-dose tumor necrosis factor-alpha in combination with interferon-gamma and melphalan for nonresectable extremity soft tissue sarcomas: a multicenter trial. J. Clin. Oncol. 14, 2653–2665 (1996).
Cited by
376 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献